Silvia von Mensdorff‐Pouilly

Author

Also Known As

M. Lomme, S von Mensdorff-Pouilly, S. Von Mensdorff-Pouilly, S. von Mensdorff-Pouilly, Silvia Mensdorff-Pouilly, Silvia Von Mensdorff-Pouilly, Silvia Von Mensdorff‐Pouilly, Silvia von Mensdorff-Pouilly, Silvia von Mensdorff‐Pouilly

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Vrije Universiteit Amsterdam Amsterdam UMC Location Vrije Universiteit Amsterdam University Medical Center Utrecht Leiden University University of Amsterdam

About

Silvia von Mensdorff‐Pouilly is an author at Vrije Universiteit Amsterdam specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	893
2	Immunology	15	17	726
3	Cell Biology	6	6	189
4	Public Health	1	1	51
5	Gastroenterology	1	1	14

Silvia von Mensdorff‐Pouilly

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Survival in Early Breast Cancer Patients Is Favorably Influenced by a Natural Humoral Immune Response to Polymorphic Epithelial Mucin Silvia von Mensdorff‐Pouilly, A.A. Verstraeten, Peter Kenemans, Journal of Clinical Oncology	2000	223
Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours Silvia von Mensdorff‐Pouilly, Maia M. Gourevitch, Peter Kenemans, European Journal of Cancer Breast OncologyCancer ImmunosurveillanceHumoral Immune ResponseEpithelial MucinImmunology	1996	134
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides andn-acetylgalactosamine (GalNAc) peptides Silvia von Mensdorff‐Pouilly, Eftichia Petrakou, Peter Kenemans, International Journal of Cancer	2000	121
Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients Silvia von Mensdorff‐Pouilly, S. V. Litvinov, Peter Kenemans, British Journal of Cancer Tumor BiologyCancer ImmunosurveillancePolymorphic Epithelial MucinMedicineImmunology	1995	111
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma Steven P. Treon, Peter Maimonis, Deborah Bua, Blood	2000	83
Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients Frank G.M. Snijdewint, Silvia von Mensdorff‐Pouilly, Augustine H. Karuntu-Wanamarta, International Journal of Cancer	2001	70
An Enzyme-Linked Immunosorbent Assay for the Measurement of Circulating Antibodies to Polymorphic Epithelial Mucin (MUC1) Silvia von Mensdorff‐Pouilly, Maia M. Gourevitch, Peter Kenemans, Tumor Biology	1998	66
Breast Cancer Immunotherapy Silvia von Mensdorff‐Pouilly Tumor ImmunologyBreast OncologyMedicineImmunologyBreast Cancer	2017	60
High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC) Marı́a Moreno, Hetty J. Bontkes, Rik J. Scheper, Cancer Letters Breast Cancer PatientsMedicineOncogenic AgentHigh LevelImmunology	2007	56
IFN-γ-Producing Human Invariant NKT Cells Promote Tumor-Associated Antigen-Specific Cytotoxic T Cell Responses Marı́a Moreno, Johan W. Molling, Silvia von Mensdorff‐Pouilly, The Journal of Immunology	2008	54

Page 1